Raju Kucherlapati
InvestorVenture Partner at Catalio Capital Management, LP Β· Member, BOD at PureTech Health
Weston, Florida
Writes $100K β $5M checks Β· typically $1.5M
Find your path to Raju
375 people in our graph share verified history with Raju β schools, employers, funds. One of them is your warm intro.
About
Raju Kucherlapati is a Professor of Genetics at Harvard Medical School. He earned his PhD from the University of Illinois Urbana-Champaign and completed postdoctoral training at Yale University, following degrees earned in India. He was elected to the National Academy of Medicine and served on the Presidential Commission for the Study of Bioethical Issues from 2009 to 2017.
Invests in
Biotech
Experience
- Harvard Medical SchoolProfessorcurrent2001 β present
- Harvard Medical SchoolProfessorcurrent2001 β present
- KEW GroupFounder and member BODcurrent2010 β presentGreater Boston Area
- Brigham and Women's HospitalProfessor of Medicinecurrent2001 β present
- PureTech HealthMember, BODcurrent2014 β presentBoston, Massachusetts, United States
- PureTech HealthMember, BODcurrent2014 β present
- PureTech HealthMember, BODcurrent2014 β present
- Metamark GeneticsMember, Board of Directors2009 β 2021Cambridge, MA
- AVEO PharmaceuticalsMember, Board of Directors2002 β 2021
- AACRmember2008 β 2015
- Enlight BiosciencesMember BOD2008 β 2010
- Harvard Partners Center for Genetics and GenomicsScientific Director2001 β 2008
- Millennium PharmaceuticalsMember, Board of Directors1993 β 2008
- AbgenixMember, Board of Directors1996 β 2006
- Albert Einstein College of MedicineProfessor1989 β 2001
- Albert Einstein College of MedicineSaul and Lola Kramer Professor and University Chairman1989 β 2001
- University of Illinois College of MedicineProfessor1982 β 1989
- Princeton UniversityAssistant Professor1975 β 1982
Skills & more
+4 more
Clinical ResearchBioinformaticsGenomicsFDALanguages English
From Raju's professional profile.
Investments
Board seats
AbgenixAVEO PharmaceuticalsCell GenesysGelesisKEW, Inc.Millennium PharmaceuticalsPureTech Health
Per the firm's website.
Colleagues at Catalio Capital Management, LP
Frequently asked questions
- Who is Raju Kucherlapati?
- Raju Kucherlapati is a Professor of Genetics at Harvard Medical School. He earned his PhD from the University of Illinois Urbana-Champaign and completed postdoctoral training at Yale University, following degrees earned in India. He was elected to the National Academy of Medicine and served on the Presidential Commission for the Study of Bioethical Issues from 2009 to 2017.
- Where does Raju Kucherlapati work?
- Raju Kucherlapati is Venture Partner at Catalio Capital Management, LP.
- What does Raju Kucherlapati invest in?
- Raju Kucherlapati invests in Biotech.
- What check size does Raju Kucherlapati write?
- Raju Kucherlapati typically writes checks of $100K β $5M.
- What boards does Raju Kucherlapati sit on?
- Raju Kucherlapati holds tracked board seats at Abgenix, AVEO Pharmaceuticals, Cell Genesys, Gelesis, KEW, Inc., Millennium Pharmaceuticals, PureTech Health.
- Where did Raju Kucherlapati go to school?
- Raju Kucherlapati studied at Yale University (Fellow, Genetics); University of Illinois Urbana-Champaign (PhD, Genetics).
Founder mafias
Yale University mafia373
Also came through, then founded or led a company.
+ 366 more
University of Illinois Urbana-Champaign mafia352
Also came through, then founded or led a company.
+ 345 more
PureTech Health mafia7
Also came through, then founded or led a company.
Catalio Capital Management, LP mafia5
Also came through, then founded or led a company.
Same school
Also attended Yale University966
+ 960 more
Also attended University of Illinois Urbana-Champaign691
+ 685 more
Shared employers
Also worked at Harvard Medical School273
+ 267 more
Also worked at Abgenix1
Also worked at Albert Einstein College of Medicine5
Also worked at University of Illinois College of Medicine11
+ 5 more




















































